BioCentury
ARTICLE | Clinical News

Maintate bisoprolol fumarate regulatory update

June 24, 2013 7:00 AM UTC

Mitsubishi said Japan approved a regulatory application to expand the label of Maintate bisoprolol fumarate tablets to include treatment of atrial fibrillation. The selective adrenergic receptor beta...